DK30391D0 - SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT - Google Patents
SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENTInfo
- Publication number
- DK30391D0 DK30391D0 DK030391A DK30391A DK30391D0 DK 30391 D0 DK30391 D0 DK 30391D0 DK 030391 A DK030391 A DK 030391A DK 30391 A DK30391 A DK 30391A DK 30391 D0 DK30391 D0 DK 30391D0
- Authority
- DK
- Denmark
- Prior art keywords
- cavitat
- clatrate
- substance consisting
- guest complexes
- contracting agent
- Prior art date
Links
- 239000000126 substance Substances 0.000 title 1
- 229940039231 contrast media Drugs 0.000 abstract 1
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000011835 investigation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/189—Host-guest complexes, e.g. cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/228—Host-guest complexes, clathrates, chelates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
The invention relates to the use of cavity- or clathrate-forming host/guest complexes as contrast media in ultrasonic, X-ray or NMR investigations.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3828905A DE3828905A1 (en) | 1988-08-23 | 1988-08-23 | MEDIALLY COMPOSED OF CAVITATE OR CLATHRATE MAKING HOST / GUEST COMPLEX AS A CONTRAST |
PCT/DE1989/000548 WO1990001952A1 (en) | 1988-08-23 | 1989-08-18 | Contrast preparation consisting of cavitate- or clathrate-forming host/guest complexes |
Publications (2)
Publication Number | Publication Date |
---|---|
DK30391A DK30391A (en) | 1991-02-21 |
DK30391D0 true DK30391D0 (en) | 1991-02-21 |
Family
ID=6361599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK030391A DK30391D0 (en) | 1988-08-23 | 1991-02-21 | SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0357163B1 (en) |
JP (1) | JP3142539B2 (en) |
AT (1) | ATE76758T1 (en) |
AU (1) | AU641363B2 (en) |
DE (2) | DE3828905A1 (en) |
DK (1) | DK30391D0 (en) |
ES (1) | ES2042986T3 (en) |
GR (1) | GR3005457T3 (en) |
IE (1) | IE65168B1 (en) |
NO (1) | NO302101B1 (en) |
PT (1) | PT91501B (en) |
WO (1) | WO1990001952A1 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
US5776429A (en) | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
US5469854A (en) | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
US6146657A (en) | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
US6001335A (en) | 1989-12-22 | 1999-12-14 | Imarx Pharmaceutical Corp. | Contrasting agents for ultrasonic imaging and methods for preparing the same |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5578292A (en) | 1991-11-20 | 1996-11-26 | Bracco International B.V. | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
US5445813A (en) | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
IN172208B (en) | 1990-04-02 | 1993-05-01 | Sint Sa | |
US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5874062A (en) | 1991-04-05 | 1999-02-23 | Imarx Pharmaceutical Corp. | Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents |
JPH06510758A (en) * | 1991-07-05 | 1994-12-01 | ニユコメド・イメージング・アクシエセルカペト | Improvements in or relating to contrast agents |
MX9205298A (en) | 1991-09-17 | 1993-05-01 | Steven Carl Quay | GASEOUS ULTRASOUND CONTRASTING MEDIA AND METHOD FOR SELECTING GASES TO BE USED AS ULTRASOUND CONTRASTING MEDIA |
US5409688A (en) * | 1991-09-17 | 1995-04-25 | Sonus Pharmaceuticals, Inc. | Gaseous ultrasound contrast media |
US6723303B1 (en) | 1991-09-17 | 2004-04-20 | Amersham Health, As | Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane |
ES2145011T5 (en) * | 1991-09-17 | 2008-02-01 | Ge Healthcare As | GAS CONTRAST MEANS FOR ECOGRAPHIES. |
IL104084A (en) * | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them |
US5558855A (en) * | 1993-01-25 | 1996-09-24 | Sonus Pharmaceuticals | Phase shift colloids as ultrasound contrast agents |
IL108416A (en) | 1993-01-25 | 1998-10-30 | Sonus Pharma Inc | Phase shift colloids as ultrasound contrast agents |
ATE200985T1 (en) * | 1993-01-25 | 2001-05-15 | Sonus Pharma Inc | PHASE PIN COLLOIDS FOR USE AS ULTRASONIC CONTRAST AGENTS |
CN1061893C (en) * | 1993-03-08 | 2001-02-14 | 柯铭清 | Acoustical contrast agent |
US5716597A (en) * | 1993-06-04 | 1998-02-10 | Molecular Biosystems, Inc. | Emulsions as contrast agents and method of use |
US5798091A (en) | 1993-07-30 | 1998-08-25 | Alliance Pharmaceutical Corp. | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
ES2231775T5 (en) | 1993-07-30 | 2011-02-02 | Imcor Pharmaceutical Co. | COMPOSITION OF STABILIZED MICROBUBBLES FOR ECOGRAPHY. |
AU679295B2 (en) | 1993-12-15 | 1997-06-26 | Bracco Suisse S.A. | Gas mixtures useful as ultrasound contrast media |
US5545396A (en) | 1994-04-08 | 1996-08-13 | The Research Foundation Of State University Of New York | Magnetic resonance imaging using hyperpolarized noble gases |
US5622687A (en) * | 1994-11-15 | 1997-04-22 | Molecular Biosystems, Inc. | Calixarene conjugates useful as MRI and CT diagnostic imaging agents |
US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5830430A (en) | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
US6033645A (en) | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
US6231834B1 (en) | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
EP0766968B1 (en) * | 1995-10-06 | 2001-01-17 | Nihon Medi-Physics Co., Ltd. | Diagnostic imaging agent |
DE19543077C2 (en) * | 1995-11-13 | 1997-10-16 | Schering Ag | Use of gas-containing metal complexes as ultrasound contrast agent |
AU721209B2 (en) * | 1996-03-05 | 2000-06-29 | Acusphere, Inc. | Microencapsulated fluorinated gases for use as imaging agents |
US5611344A (en) * | 1996-03-05 | 1997-03-18 | Acusphere, Inc. | Microencapsulated fluorinated gases for use as imaging agents |
JP2001507207A (en) | 1996-05-01 | 2001-06-05 | イマアーレクス・フアーマシユーチカル・コーポレーシヨン | Methods for delivering compounds to cells |
US6414139B1 (en) | 1996-09-03 | 2002-07-02 | Imarx Therapeutics, Inc. | Silicon amphiphilic compounds and the use thereof |
US5846517A (en) | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
DE19709704C2 (en) | 1997-03-10 | 1999-11-04 | Michael Georgieff | Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia |
US6143276A (en) | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6537246B1 (en) | 1997-06-18 | 2003-03-25 | Imarx Therapeutics, Inc. | Oxygen delivery agents and uses for the same |
US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6548047B1 (en) | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
US6284222B1 (en) | 1998-11-03 | 2001-09-04 | Medi--Physics, Inc. | Hyperpolarized helium-3 microbubble gas entrapment methods |
DE19851605A1 (en) * | 1998-11-09 | 2000-05-11 | Messer Griesheim Gmbh | Injection anesthetic containing microparticles |
JP4544551B2 (en) * | 1999-07-28 | 2010-09-15 | 日本曹達株式会社 | Molecular compounds containing tri-o-thymotides as component compounds |
WO2002045721A1 (en) * | 2000-12-04 | 2002-06-13 | Uws Ventures Limited | Noble gas complexes |
US8012457B2 (en) | 2004-06-04 | 2011-09-06 | Acusphere, Inc. | Ultrasound contrast agent dosage formulation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4276885A (en) * | 1979-05-04 | 1981-07-07 | Rasor Associates, Inc | Ultrasonic image enhancement |
US4718433A (en) * | 1983-01-27 | 1988-01-12 | Feinstein Steven B | Contrast agents for ultrasonic imaging |
DE3637926C1 (en) * | 1986-11-05 | 1987-11-26 | Schering Ag | Ultrasonic manometry in a liquid using microbubbles |
-
1988
- 1988-08-23 DE DE3828905A patent/DE3828905A1/en not_active Ceased
-
1989
- 1989-08-18 EP EP89250016A patent/EP0357163B1/en not_active Expired - Lifetime
- 1989-08-18 WO PCT/DE1989/000548 patent/WO1990001952A1/en unknown
- 1989-08-18 ES ES89250016T patent/ES2042986T3/en not_active Expired - Lifetime
- 1989-08-18 AT AT89250016T patent/ATE76758T1/en not_active IP Right Cessation
- 1989-08-18 AU AU40651/89A patent/AU641363B2/en not_active Ceased
- 1989-08-18 JP JP01508694A patent/JP3142539B2/en not_active Expired - Fee Related
- 1989-08-18 DE DE8989250016T patent/DE58901585D1/en not_active Expired - Lifetime
- 1989-08-18 IE IE268589A patent/IE65168B1/en not_active IP Right Cessation
- 1989-08-22 PT PT91501A patent/PT91501B/en not_active IP Right Cessation
-
1991
- 1991-02-21 DK DK030391A patent/DK30391D0/en not_active Application Discontinuation
- 1991-02-22 NO NO910711A patent/NO302101B1/en not_active IP Right Cessation
-
1992
- 1992-08-20 GR GR920401406T patent/GR3005457T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU4065189A (en) | 1990-03-23 |
JPH04501559A (en) | 1992-03-19 |
DK30391A (en) | 1991-02-21 |
DE58901585D1 (en) | 1992-07-09 |
NO302101B1 (en) | 1998-01-26 |
PT91501B (en) | 1995-05-31 |
DE3828905A1 (en) | 1990-03-15 |
PT91501A (en) | 1990-03-08 |
IE65168B1 (en) | 1995-10-04 |
AU641363B2 (en) | 1993-09-23 |
WO1990001952A1 (en) | 1990-03-08 |
NO910711L (en) | 1991-02-22 |
JP3142539B2 (en) | 2001-03-07 |
NO910711D0 (en) | 1991-02-22 |
ATE76758T1 (en) | 1992-06-15 |
GR3005457T3 (en) | 1993-05-24 |
ES2042986T3 (en) | 1993-12-16 |
EP0357163A1 (en) | 1990-03-07 |
IE892685L (en) | 1990-02-23 |
EP0357163B1 (en) | 1992-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK30391D0 (en) | SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT | |
NO161366C (en) | NEW 1,3-CYCL HEXANDON DERIVATIVES AND USE THEREOF AS HERBICID AGENT. | |
DE3485162D1 (en) | AMINOMETHYLOXOOXAZOLIDINYL-BENZOL DERIVATIVES USED AS ANTIBACTERIAL AGENTS. | |
IT8419216A0 (en) | MEDICAL INSTRUMENT. | |
FI853207A0 (en) | DIAGNOSTIC OCH CONTRAST METHODS. | |
NO910399D0 (en) | USE OF TRIALCANOLAMINE POLYETERS AS DEMULGATORS FOR OIL-IN-WATER EMULSIONS. | |
ATE89169T1 (en) | AGENT CONTAINING ANTICOAGULANT. | |
SE7709328L (en) | X-RAY CONTRAST AGENT | |
NO903863L (en) | TIAZOLIDE INDION DERIVATIVES AS HYPOGLYCHEMIC AGENTS. | |
DK0557345T3 (en) | 1,3-bis- (3- (mono- or polyhydroxy) acylamino-5- (mono- or polyhydroxyalkyl) aminocarbonyl-2,4,6-triiodobenzoylamino) -hydroxy- or hydroxyalkyl-propanes, processes for their preparation and X-ray contrast agents containing these | |
DK137945B (en) | Triiodobenzene derivatives for use as X-ray contrast agents. | |
DE69106138D1 (en) | SYRINGE DEVICE FOR LIQUID MIXTURES, ESPECIALLY FOR DENTAL PURPOSES. | |
NO894840D0 (en) | BROWN TREATMENT FLUID ADDITIVE. | |
ITMI920955A1 (en) | POLYETEREAMIDOAMINE TYPE HYDROGEL AS EPARINIZABLE MATERIALS | |
SE7811491L (en) | NEW POLYSACCARIDE, PROCEDURE FOR ITS PREPARATION AND HYPOCOLESTEROL COMPOSITION CONTAINING THE NEW ASSOCIATION | |
NO875466L (en) | COMPLEXES OF BISMUT OR ANTIMONAL HALOGENIDES AND AMINES, PROCEDURES FOR THE PREPARATION OF THEM, AND POLYMERS CONTAINING THE COMPLEXES AS FLAMMETIC AGENTS. | |
NO901452D0 (en) | MIXTURES CONTAINING 2-TIOCYANO-METHYLTIO-BENZOTIAZOL FOR USE AS INDUSTRIAL MICROBIOCIDS. | |
ES2039211T3 (en) | NEW N-GLYCOSILAMIDODERIVES, PROCEDURES FOR THEIR OBTAINING AND USE AS MEDICINES. | |
ATE130304T1 (en) | NEW ALPHA-GLUCOSIDASINE INHIBITORS. | |
NO162212C (en) | MYCOHERBICID CONCENTRATE, HERBICID AGENT AND USE THEREOF. | |
NO893847D0 (en) | DOUBLE POSE FOR USE AS EXTERNAL LONG. | |
DK137311B (en) | Triiodobenzene derivatives for use as X-ray contrast agents. | |
DK165789C (en) | 4-OXO-4H-PYRIMIDOOE2,1, AAAISOQUINOLINE DERIVATIVES, ANALOGUE PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL PREPARATION CONTAINING THESE, AND THE DERIVATIVES FOR USE AS ANTI-ANALYSIS | |
FI910076A0 (en) | PAOSE FOER FOERBRUKADE, VID SURGICAL OPERATIONER ANVAENDA ENGAONGSARTIKLAR, SAOSOM OPERATIONSDUKAR OCH KOMPRESSER. | |
DE3485217D1 (en) | BLOOD PRESSURE COMPOSITION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |